Krishak Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-07-2024
- Paid Up Capital ₹ 0.10 M
as on 08-07-2024
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 1.50 M
as on 08-07-2024
- Revenue 40.10%
(FY 2020)
- Profit 10.89%
(FY 2020)
- Ebitda -27.86%
(FY 2020)
- Net Worth 4.27%
(FY 2020)
- Total Assets 4.08%
(FY 2020)
About Krishak Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 M.
Minal Joshi and Sanjay Joshi serve as directors at the Company.
- CIN/LLPIN
U24210MH2008PTC178699
- Company No.
178699
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 2008
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Krishak Biotech Private Limited offer?
Krishak Biotech Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Micronutrient Fertilizers, Organic Fertilizers and Manure, Fertilizer.
Who are the key members and board of directors at Krishak Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Minal Joshi  | Director | 09-Feb-2008 | Current |
| Sanjay Joshi | Director | 09-Feb-2008 | Current |
Financial Performance of Krishak Biotech.
Krishak Biotech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 40.1% increase. The company also saw a substantial improvement in profitability, with a 10.89% increase in profit. The company's net worth moved up by a moderate rise of 4.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krishak Biotech?
In 2019, Krishak Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Jalgaon Janata Sahakari Bank Limited Creation Date: 28 Feb 2011 | ₹0.75 M | Open |
Jalgaon Janata Sahakari Bank Limited Creation Date: 25 Feb 2011 | ₹0.75 M | Open |
How Many Employees Work at Krishak Biotech?
Unlock and access historical data on people associated with Krishak Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krishak Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krishak Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
